Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
about
PPARs and the cardiovascular systemEffects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.4-Thiazolidinone derivative Les-3833 effectively inhibits viability of human melanoma cells through activating apoptotic mechanisms.Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesThe Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferationIs peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients.Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.The potential of antidiabetic thiazolidinediones for anticancer therapy.Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism.Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and LactationThe possible role of peroxisome proliferator-activated receptor gamma in heart failure.Distinct functions of vascular endothelial and smooth muscle PPARgamma in regulation of blood pressure and vascular tone.PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.PPARgamma as a potential therapeutic target in pulmonary hypertension.Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease.Thiazolidinedione safety.L-Arginine and its metabolites in kidney and cardiovascular disease.Protective Actions of PPAR-gamma Activation in Renal Endothelium.Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.Transforming growth factor-beta1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1.Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat.Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells.A meta-analysis of the effect of thiazolidinediones on blood pressure.Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience.UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis.
P2860
Q24642728-81D448B2-3BEB-4901-8743-E9E302818CABQ33231599-EFA7B36D-F539-4E0F-A7A6-DB4C0CABE7D5Q33619953-3A642D69-06C5-453C-8969-FCB5731C6EFBQ33797616-02047B76-ACB2-4D95-BC6A-C709A224D1B2Q34294854-A8767DE1-A1B7-4060-BB3E-11B10864BF37Q34897476-ACB7CAFB-B2B2-4DC6-969C-AD644B891884Q35030013-A42654B0-65C0-4BFD-B8C3-8D68C79E96FDQ36068458-68C376CB-44F4-47C9-B807-3EB44807C242Q36568732-5A79C47C-471C-4632-8C1B-DF280CF35BFBQ36632030-07BFEC41-CAE8-4A10-B779-DE4B8E0E7C8EQ36692337-C1808EDD-D4D6-4A3A-A724-78B8217420ACQ36853537-C8DCACAF-FB86-4E40-BA89-D2356C852179Q37277818-D45D05D9-1E44-4288-8BB2-B46DD5D3A9ADQ37468639-97E71F8E-0CD0-42AA-85D1-9ABAA0559769Q37521530-9DF5F46A-BD03-4E92-860B-F065EF433CBBQ37689190-38916DD4-583F-43BD-AF66-E4AE3B2800EAQ37943863-F3FD720C-FA2B-4609-9D17-55FF4AD5FDAAQ38012205-CB43392B-2F3D-4C06-B0BB-40D4219BCA8EQ38243758-E19465BB-CA3D-4D51-8730-FC642EABFC58Q42008239-25E29359-44DC-44A3-BCB3-204DFCDD8314Q42210954-B48B18BE-D38E-4089-8620-48DCCFE13106Q42923091-23AAB9DE-5223-4395-A946-98B5E303B768Q43109238-23A37FD4-DDAB-4258-9133-F43472853A23Q43141220-3106F269-57BB-4A34-823B-D61FC3A663F1Q44525843-6E786491-8325-4B45-950E-D03508AFBB19Q46890745-595EB2EE-BA5A-47AB-8404-6FBCFDEE9F49Q46891969-25D494EB-37C6-42EC-B5F2-5AE22D3CE691Q47410522-BC4CB5D0-F0BC-44E4-A36B-A7B4298BB3A7
P2860
Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@en
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@nl
type
label
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@en
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@nl
prefLabel
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@en
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@nl
P2093
P1433
P1476
Thiazolidinediones, peroxisome ...... retion of vasoactive peptides.
@en
P2093
Fukunaga Y
Masatsugu K
P304
P356
10.1016/S0021-9150(01)00430-0
P577
2001-09-01T00:00:00Z